Improvement of scleromyxedema associated with isotretinoin therapy.
 The treatment of scleromyxedema has been largely ineffective.
 We report improvement of scleromyxedema with myopathy after treatment with isotretinoin, 40 mg twice a day.
 We review other therapeutic modalities used for this disorder and discuss properties of isotretinoin that may have contributed to the favorable response.
